Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. ToolGen Incorporated
  6. News
  7. Summary
    A199800   KR7199800004

TOOLGEN INCORPORATED

(A199800)
SummaryChartsNewsCompanyConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ToolGen, Inc., Demonstrates CRISPR/Cas9 Gene Editing Improves Anti-Tumor Activity of Human Car-T Cells

05/17/2018 | 02:48pm EDT

ToolGen Inc. announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the company's CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model. The study is being presented in a poster presentation at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting held May 16 to May 9, 2018, in Chicago.


ę S&P Capital IQ 2018
All news about TOOLGEN INCORPORATED
2018ToolGen, Inc., Demonstrates CRISPR/Cas9 Gene Editing Improves Anti-Tumor Acti..
CI
2017Monsanto Company and ToolGen, Inc. Announce Global Licensing Agreement on CRI..
CI
2017ToolGen, Inc. Highlights Study Results Demonstrating Utility of AAV-Compatibl..
CI
2016ToolGen Incorporated announced that it has received KRW 10.0223744 billion in..
CI
2016ToolGen Incorporated announced that it expects to receive KRW 10.0223744 bill..
CI
More news
Chart TOOLGEN INCORPORATED
Duration : Period :
ToolGen Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 148 500,00 
Average target price
Spread / Average Target -
Managers and Directors
Byung-Hwa Lee Co-Chief Executive Officer & Director
Young-Ho Kim Co-Chief Executive Officer & Director
Il-Ho Ha Independent Director
Seok-Joong Kim Director & Head-Business Development
Jong-Hyun Jang Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
TOOLGEN INCORPORATED33.78%826
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420